Table of Content

1. Executive Summary
1.1. Global Rare Gastrointestinal Diseases Treatment Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 – 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Treatment Type Lifecycle Analysis
2.4. Global Rare Gastrointestinal Diseases Treatment Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force’s Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors – Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Rare Gastrointestinal Diseases Treatment Market Outlook: Historical (2018 – 2022) and Forecast (2023 – 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013–2016
3.2.2. Current Market Size Forecast, 2018–2026
3.3. Global Rare Gastrointestinal Diseases Treatment Market Outlook: Treatment Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2018 – 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 – 2030
3.3.3.1. Medications
3.3.3.2. Nutritional Support
3.4. Market Attractiveness Analysis: Treatment Type
3.5. Global Rare Gastrointestinal Diseases Treatment Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 – 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 – 2030
3.5.3.1. Hospitals
3.5.3.2. Research Institutes
3.5.3.3. Other End User Settings
3.6. Market Attractiveness Analysis: End User
4. Global Rare Gastrointestinal Diseases Treatment Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 – 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 – 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Global Rare Gastrointestinal Diseases Treatment Market Outlook: Historical (2018 – 2022) and Forecast (2023 – 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 – 2022
5.3.1. By Country
5.3.2. By Treatment Type
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 – 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 – 2030
5.5.1. Medications
5.5.2. Nutritional Support
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 – 2030
5.6.1. Hospitals
5.6.2. Research Institutes
5.6.3. Other End User Settings
5.7. Market Attractiveness Analysis
6. Europe Global Rare Gastrointestinal Diseases Treatment Market Outlook: Historical (2018 – 2022) and Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 – 2022
6.3.1. By Country
6.3.2. By Treatment Type
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 – 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 – 2030
6.5.1. Medications
6.5.2. Nutritional Support
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 – 2030
6.6.1. Hospitals
6.6.2. Research Institutes
6.6.3. Other End User Settings
6.7. Market Attractiveness Analysis
7. East Asia Global Rare Gastrointestinal Diseases Treatment Market Outlook: Historical (2018 – 2022) and Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 – 2022
7.3.1. By Country
7.3.2. By Treatment Type
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 – 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 – 2030
7.5.1. Medications
7.5.2. Nutritional Support
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 – 2030
7.6.1. Hospitals
7.6.2. Research Institutes
7.6.3. Other End User Settings
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Global Rare Gastrointestinal Diseases Treatment Market Outlook: Historical (2018 – 2022) and Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 – 2022
8.3.1. By Country
8.3.2. By Treatment Type
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 – 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 – 2030
8.5.1. Medications
8.5.2. Nutritional Support
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 – 2030
8.6.1. Hospitals
8.6.2. Research Institutes
8.6.3. Other End User Settings
8.7. Market Attractiveness Analysis
9. Latin America Global Rare Gastrointestinal Diseases Treatment Market Outlook: Historical (2018 – 2022) and Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 – 2022
9.3.1. By Country
9.3.2. By Treatment Type
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 – 2030
9.5.1. Medications
9.5.2. Nutritional Support
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 – 2030
9.6.1. Hospitals
9.6.2. Research Institutes
9.6.3. Other End User Settings
9.7. Market Attractiveness Analysis
10. Middle East & Africa Global Rare Gastrointestinal Diseases Treatment Market Outlook: Historical (2018 – 2022) and Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 – 2022
10.3.1. By Country
10.3.2. By Treatment Type
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 – 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 – 2030
10.5.1. Medications
10.5.2. Nutritional Support
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 – 2030
10.6.1. Hospitals
10.6.2. Research Institutes
10.6.3. Other End User Settings
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Treatment Type Capacity
11.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
11.3.1. Bayer Pharmaceutical Corp
11.3.1.1. Overview
11.3.1.2. Segments and Treatment Type
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Teva Pharmaceutical
11.3.2.1. Overview
11.3.2.2. Segments and Treatment Type
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Novartis AG
11.3.3.1. Overview
11.3.3.2. Segments and Treatment Type
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Sanofi
11.3.4.1. Overview
11.3.4.2. Segments and Treatment Type
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Pfizer, Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Treatment Type
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. GlaxoSmithKline PLC
11.3.6.1. Overview
11.3.6.2. Segments and Treatment Type
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Eli Lilly and CO.
11.3.7.1. Overview
11.3.7.2. Segments and Treatment Type
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Johnson & Johnson
11.3.8.1. Overview
11.3.8.2. Segments and Treatment Type
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations